Skip to content
The Policy VaultThe Policy Vault

Gleevec (imatinib tablets) — Cigna

Myeloid/Lymphoid Neoplasms with Eosinophilia

Initial criteria

  • Patient age ≥ 18 years
  • Tumor has ABL1 rearrangement OR FIP1L1-PDGFRA or PDGFRB rearrangement

Approval duration

1 year